| Revenue growth | FY26: (16)% YoY; Q4FY26: (12)% YoY |
|---|---|
| Margins | FY26 EBITDA margin at 25%, guided target achieved. |
| Order book | Order book remains supportive for FY27. |
| Demand visibility | Strong order book continues to support FY27 growth outlook. |
| Management confidence | Cautious optimism for H2FY27 based on customer offtake plans. |
Growth
FY26 revenue fell 16% to ₹67,137 Mn; EBITDA dropped 22% to ₹17,053 Mn. Pharma grew 40% Y-o-Y.
Outlook
Guided for 5+ new molecule launches in FY27; total FY26 capex stood at ₹11,508 Mn.
Risks
Global agrochemical industry contraction, elevated domestic inventory leading to pricing pressure, and adverse weather conditions impacting demand.
Earnings Call filed with BSE, NSE: PIIND. Summary written with AI assistance from the document.
PI Industries Ltd: key numbers
- Share price
- ₹2,210.00
- Market cap
- ₹33,530 Cr
- Revenue (annual)
- ₹6,714 Cr
- Net profit (annual)
- ₹1,321 Cr
- P/E (TTM)
- 28.8×Sector 37.2×
- Promoter holding
- 46.09%+0.00% QoQ
- FII holding
- 14.83%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PI Industries Ltd
All →PI Industries Other Announcement
Bhavina J Dholariya, an immediate relative of an insider, sold equity shares of PI Industries Ltd. The market sale was valued at ₹0.12 Crore.
- Value
- ₹0.12 Cr
PI Industries Product Launch
PI Industries received registration for its indigenously developed insecticide, 'Pioxaniliprole' (branded 'Pioxazon'), marking a key milestone in its agricultural innovation journey.
PI Industries Other Announcement
Designated person Jayesh Dholariya disclosed the sale of 3,000 equity shares via gift, totaling approximately Rs. 0.75 Crore.
- Value
- ₹0.75 Cr
PI Industries Annual General Meeting
PI Industries held its 79th Annual General Meeting on August 14, 2026. Shareholders approved all nine agenda items, including financial statements and dividend payments.
PI Industries Earnings Call Transcript: Key Takeaways
PI Industries Q1 FY27 results show resilience amidst global agrochemical headwinds, maintaining healthy EBITDA margins at 22% despite revenue softness. Management remains optimistic about a second-half recovery driven by domestic monsoon improvement and new product scale-ups.
- Call
- Guides 5% growth
PI Industries Investor Presentation: Key Takeaways
PI Industries Q1 FY27 consolidated revenue fell 10% to ₹17,023 Mn, with EBITDA down 29% and PAT down 39% due to global agrochemical headwinds and cyclical disruptions.